U.S., U.K. health care systems share a fatal flaw A focus on clinical interventions instead of community-based preventive care

https://www.statnews.com/2026/08/14/us-uk-health-care-systems-loneliness-community-prevention/ By Kyle VanelliAug. 14, 2026 Vanelli is a policy and data analyst at Local Trust.

Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism Valisure claims U.S. Pharmacopeia made false statements about its methods for uncovering safety issues

https://www.statnews.com/pharmalot/2026/08/14/controversial-lab-sues-usp-for-disparaging-its-testing-methods/ By Ed SilvermanAug. 14, 2026 Pharmalot Columnist, Senior Writer

Commure terminates payments under its customer referral programs tied to AI products The referral programs were the focus of a STAT investigation published Aug. 12

https://www.statnews.com/2026/08/13/commure-terminates-payments-under-customer-referral-programs/ By Casey Ross and Brittany TrangAug. 13, 2026

AAP president: How pediatricians are navigating federal leaders’ fearmongering on vaccines In an unsettling time, pediatricians are offering guidance and reassurance

https://www.statnews.com/2026/08/14/vaccine-executive-order-policy-aap-president/ By Andrew D. RacineAug. 14, 2026 Racine is president of the American Academy of Pediatrics.

Epic’s alleged anticompetitive practices under scrutiny from federal, state investigators Federal Trade Commission officials have reached out to at least four people in recent months

https://www.statnews.com/2026/08/14/epic-systems-ftc-review-nda-use-possible-anticompetitive-practices/ By Casey Ross and Brittany TrangAug. 14, 2026

FDA Turns the Spotlight on Regulatory Science: What Medical Device Developers Need to Know August 14, 2026 By Jennifer D. Newberger —

https://www.thefdalawblog.com/2026/08/fda-turns-the-spotlight-on-regulatory-science-what-medical-device-developers-need-to-know/?utm_source=rss&utm_medium=rss&utm_campaign=fda-turns-the-spotlight-on-regulatory-science-what-medical-device-developers-need-to-know CDRH’s September 25 public meeting offers a front-row seat to the science shaping the future of medical device review. Last week, the FDA’s Center for Devices and Radiological Health (CDRH) announced a public meeting titled “Regulatory Science Innovations Catalyzing Medical Device Development,” scheduled for September 25, 2026. For companies developing, manufacturing, or investing in medical devices, this event offers a rare opportunity to hear directly from the agency about the scientific tools and evidence standards that increasingly shape product review and approval decisions.

Remembering Bob Blendon, An Essential Professor, Teacher, And Mentor Mollyann Brodie August 10, 2026

https://www.healthaffairs.org/content/forefront/remembering-bob-blendon-essential-professor-teacher-and-mentor?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-9hOT9kuEePQsEWngmRe7DHprrNM9qLbf0w-v7mlCfMyRQRDr9Cp6Nfs1raN6JlHYHcbXctQViPzA0AwcdCozGL-vjPBA&_hsmi=433307009&utm_source=hasu It wasn’t just his advice and his connections that made him an exceptional mentor and teacher. It was how he treated you, making you feel like a valued member of the community.